BeOne Medicines is a global oncology company founded in 2010 and headquartered in Basel, Switzerland, operating in over 45 countries. The company maintains one of the largest oncology research teams with more than 1,100 scientists and over 3,700 clinical development professionals. BeOne develops and commercializes cancer treatments including BRUKINSA (zanubrutinib) and TEVIMBRA (tislelizumab), both approved in over 75 countries and used to treat more than 1.7 million patients worldwide. It is involved in over 170 clinical trials and advances a robust pipeline of more than 40 assets across various development stages. With a mission to unite the global community against cancer, the company emphasizes speed, cost efficiency, and scientific rigor to make cancer treatments more accessible and effective globally.
BeOne Medicines
Global oncology company developing innovative cancer therapies and conducting extensive clinical trials.
Open positions at BeOne Medicines
0 active listings